Disciplined Investments, LLC Repligen Corp Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$138.42 - $180.31 $276 - $360	-2 Reduced 33.33%	4 $0
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $154 - $198	1 Added 20.0%	6 $1,000
Q4 2022 Feb 01, 2023	SELL	$162.42 - $220.56 $162 - $220	-1 Reduced 16.67%	5 $0
Q3 2022 Nov 03, 2022	BUY	$160.42 - $256.21 $641 - $1,024	4 Added 200.0%	6 $1,000
Q2 2022 Aug 09, 2022	SELL	$140.68 - $188.02 $281 - $376	-2 Reduced 50.0%	2 $0
Q1 2022 Apr 22, 2022	BUY	$161.19 - $257.96 $644 - $1,031	4 New	4 $1,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.